EU TRANSPARENCY REGISTER · 0089331103484-06 · Netherlands

Emma van der Leest Design & Research

Category

Think tanks and research institutions

Country

Netherlands

Rotterdam

Entity form

eenmanszaak

Stated objectives

Emma van der Leest is een biodesigner die werkt op het snijvlak van design, wetenschap en duurzaamheid. Haar activiteiten richten zich op het ontwikkelen van biomaterialen met organismen. Ze is oprichter van BlueCity Lab, waar ze samen met …

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2026-04-02

Other Think tanks and research institutions in Netherlands

Other registered organisations in Netherlands

Frequently asked questions

What is this organisation?
Emma van der Leest Design & Research is an interest representative listed in the EU Joint Transparency Register under ID 0089331103484-06. Entity form: eenmanszaak.
What category is it registered under?
It is registered under the category "Think tanks and research institutions".
Which country is it based in?
The organisation is based in Netherlands, Rotterdam.
What are its stated goals?
As declared by the registrant: Emma van der Leest is een biodesigner die werkt op het snijvlak van design, wetenschap en duurzaamheid. Haar activiteiten richten zich op het ontwikkelen van biomaterialen met organismen. Ze is oprichter van BlueCity Lab, waar ze samen met …
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 0089331103484-06.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-02 · Commission Reuse Decision 2011/833/EU